Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Chemotherapy triggers HIF-1-dependent glutathione synthesis and copper chelation that induces the breast cancer stem cell phenotype.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: August 01, 2015
HIF-1α and TAZ serve as reciprocal co-activators in human breast cancer cells.
Journal: Oncotarget
Published: May 05, 2015
Hypoxia-inducible factors enhance glutamate signaling in cancer cells.
Journal: Oncotarget
Published: October 20, 2014
Cyclin-dependent kinases regulate lysosomal degradation of hypoxia-inducible factor 1α to promote cell-cycle progression.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: July 30, 2014
Ganetespib blocks HIF-1 activity and inhibits tumor growth, vascularization, stem cell maintenance, invasion, and metastasis in orthotopic mouse models of triple-negative breast cancer.
Journal: Journal of molecular medicine (Berlin, Germany)
Published: October 01, 2013
Sirtuin-7 inhibits the activity of hypoxia-inducible factors.
Journal: The Journal of biological chemistry
Published: June 11, 2013
Chaperone-mediated autophagy targets hypoxia-inducible factor-1α (HIF-1α) for lysosomal degradation.
Chaperone-mediated autophagy targets hypoxia-inducible factor-1α (HIF-1α) for lysosomal degradation.
Journal: The Journal of biological chemistry
Published: March 05, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026